VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-0.55%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.73B
AUM Growth
+$336M
(+24%)
Cap. Flow
+$415M
Cap. Flow
% of AUM
23.97%
Top 10 Holdings %
Top 10 Hldgs %
59.34%
Holding
67
New
13
Increased
7
Reduced
17
Closed
3
Top Buys
| 1 |
ALX Oncology
ALXO
|
+$159M |
| 2 |
Harmony Biosciences
HRMY
|
+$154M |
| 3 |
Novavax
NVAX
|
+$17.8M |
| 4 |
Nkarta
NKTX
|
+$15.4M |
| 5 |
Cytokinetics
CYTK
|
+$15.2M |
Top Sells
| 1 |
Verastem
VSTM
|
+$7.98M |
| 2 |
Legend Biotech
LEGN
|
+$6.94M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
+$5.16M |
| 4 |
Zymeworks
ZYME
|
+$4.37M |
| 5 |
Galmed Pharmaceuticals
GLMD
|
+$4.11M |
Sector Composition
| 1 | Healthcare | 91.47% |
| 2 | Financials | 6.31% |
| 3 | Materials | 2.22% |
